Dongwha Pharm.Co.Ltd (000020) — Cash Flow-to-Debt Ratio
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of ₩697.02 Million could theoretically repay 0% of its total liabilities (₩238.27 Billion) in one year. See how financially flexible is Dongwha Pharm.Co.Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dongwha Pharm.Co.Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Dongwha Pharm.Co.Ltd across 15 annual periods. For the full cash flow conversion analysis, see Dongwha Pharm.Co.Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year debt coverage analysis for Dongwha Pharm.Co.Ltd. Check Dongwha Pharm.Co.Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩15.70 Billion | ₩240.73 Billion | ▲ +455.1% |
| 2024 | -0.02x | ₩-4.00 Billion | ₩217.96 Billion | ▼ -109.9% |
| 2023 | 0.18x | ₩29.17 Billion | ₩157.92 Billion | ▼ -47.9% |
| 2022 | 0.35x | ₩29.22 Billion | ₩82.46 Billion | ▼ -13.8% |
| 2021 | 0.41x | ₩36.03 Billion | ₩87.67 Billion | ▼ -28.3% |
| 2020 | 0.57x | ₩52.23 Billion | ₩91.13 Billion | ▲ +224.2% |
| 2019 | 0.18x | ₩13.28 Billion | ₩75.15 Billion | ▲ +396.8% |
| 2018 | -0.06x | ₩-4.36 Billion | ₩73.20 Billion | ▲ +74.7% |
| 2017 | -0.24x | ₩-16.52 Billion | ₩70.28 Billion | ▼ -166.1% |
| 2016 | 0.36x | ₩25.48 Billion | ₩71.68 Billion | ▲ +56.1% |
| 2015 | 0.23x | ₩19.83 Billion | ₩87.07 Billion | ▲ +40.5% |
| 2014 | 0.16x | ₩13.51 Billion | ₩83.35 Billion | ▲ +75.8% |
| 2013 | 0.09x | ₩8.21 Billion | ₩88.93 Billion | ▼ -64.4% |
| 2012 | 0.26x | ₩25.23 Billion | ₩97.29 Billion | ▼ -38.4% |
| 2011 | 0.42x | ₩46.24 Billion | ₩109.81 Billion | — |